Malaria sickness Travelers and Treatment

Malaria is caused by the protozoan parasite Plasmodium. Human malaria is caused by four different species of Plasmodium: P. falciparum, P. malaria, P. ovale and P. vivax. Humans occasionally become infected with Plasmodium species that normally infect animals, such as P. knowlesi. As yet, there are no reports of human-mosquitohuman transmission of such “zoonotic” forms of malaria. The malaria parasite is transmitted by female Anopheles mosquitoes, which bite mainly between dusk and dawn. Malaria is an acute febrile illness with incubation period of 7 days or longer. Thus, a febrile illness developing less than 1 week after the first possible exposure is not malaria.

With the burgeoning response and grand success of OMICS International's "5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" held on July 27-28, 2015 in Brisbane, Australia, OMICS International takes the pride of announcing the grand commencement of International Conference on Travel Medicine & Vaccines scheduled during August 01-02 in Seattle, USA.

List of Best International Conferences:

·         10th Euro Vaccines Conference June 16-18, 2016 Rome, Italy

·         13th Vaccines Asia Pacific Conference, November 10-12, 2016 Melbourne, Australia

·         7th Middle East Vaccines Conference, September 28-30, 2015 Dubai, UAE

·         12th American Vaccines Conference, Oct 20-22, 2016, Dubai, UAE

·         Virulent HIV Vaccines conference Oct 3-5, 2016 Miami, USA

·         The Arthropod Vector: The Controller of Transmission (E2), USA

·         3rd Conference on Neglected Vectors and Vector-Borne Diseases, Spain

·         Emerging Vector-borne Diseases in a Changing European Environment, France

·         The XIX International Congress for Tropical Medicine and Malaria, Australia

·         18th Annual Conference on Vaccine Research, USA


The risk of disease can be reduced by preventing mosquito bites by using mosquito nets and insect repellents, or with mosquito-control measures such as spraying insecticides and draining standing water. Several medications are available to prevent malariain travellers to areas where the disease is common. Occasional doses of the medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effectivevaccine exists, although efforts to develop one are ongoing.[1] The recommended treatment for malaria is a combination ofantimalarial medications that includes an artemisinin. The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine. Quinine along with doxycycline may be used if an artemisinin is not available. It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasingdrug resistance. Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.

  • transmission
  • life-threatening Conditions
  • Care to be taken
  • Others

Related Conference of Malaria sickness Travelers and Treatment

Malaria sickness Travelers and Treatment Conference Speakers

Recommended Sessions

Related Journals

Are you interested in